Literature DB >> 7825350

The clinical use of desflurane.

E I Eger1.   

Abstract

Desflurane, a newly introduced potent, inhaled anesthetic, differs from its predecessors in having a lower solubility in blood and tissues. The lower solubility imparts a greater control to the maintenance of anesthesia and a more rapid elimination and recovery from anesthesia. In other respects, the pharmacological properties of desflurane resemble those of its sister anesthetic, isoflurane, currently the most widely-used potent anesthetic in this and other countries. The qualitative exceptions to this resemblence are that desflurane is more pungent and produces a greater increase in heart rate, particularly at deeper levels of anesthesia.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7825350      PMCID: PMC2588873     

Source DB:  PubMed          Journal:  Yale J Biol Med        ISSN: 0044-0086


  25 in total

1.  Kinetics of desflurane, isoflurane, and halothane in humans.

Authors:  N Yasuda; S H Lockhart; E I Eger; R B Weiskopf; B H Johnson; B A Freire; A Fassoulaki
Journal:  Anesthesiology       Date:  1991-03       Impact factor: 7.892

2.  Comparison of kinetics of sevoflurane and isoflurane in humans.

Authors:  N Yasuda; S H Lockhart; E I Eger; R B Weiskopf; J Liu; M Laster; S Taheri; N A Peterson
Journal:  Anesth Analg       Date:  1991-03       Impact factor: 5.108

3.  A comparison of desflurane and isoflurane in patients undergoing coronary artery surgery.

Authors:  I R Thomson; J B Bowering; R J Hudson; M A Frais; M Rosenbloom
Journal:  Anesthesiology       Date:  1991-11       Impact factor: 7.892

4.  Comparison of the systemic and coronary hemodynamic actions of desflurane, isoflurane, halothane, and enflurane in the chronically instrumented dog.

Authors:  P S Pagel; J P Kampine; W T Schmeling; D C Warltier
Journal:  Anesthesiology       Date:  1991-03       Impact factor: 7.892

5.  Depression of ventilation by desflurane in humans.

Authors:  S H Lockhart; I J Rampil; N Yasuda; E I Eger; R B Weiskopf
Journal:  Anesthesiology       Date:  1991-03       Impact factor: 7.892

6.  The risk of myocardial ischemia in patients receiving desflurane versus sufentanil anesthesia for coronary artery bypass graft surgery. The S.P.I. Research Group.

Authors:  J D Helman; J M Leung; W H Bellows; N Pineda; G W Roach; J D Reeves; J Howse; M T McEnany; D T Mangano
Journal:  Anesthesiology       Date:  1992-07       Impact factor: 7.892

7.  Fluoride metabolites after prolonged exposure of volunteers and patients to desflurane.

Authors:  T S Sutton; D D Koblin; L D Gruenke; R B Weiskopf; I J Rampil; L Waskell; E I Eger
Journal:  Anesth Analg       Date:  1991-08       Impact factor: 5.108

8.  Cardiovascular actions of desflurane in normocarbic volunteers.

Authors:  R B Weiskopf; M K Cahalan; E I Eger; N Yasuda; I J Rampil; P Ionescu; S H Lockhart; B H Johnson; B Freire; S Kelley
Journal:  Anesth Analg       Date:  1991-08       Impact factor: 5.108

9.  Desflurane is a trigger of malignant hyperthermia in susceptible swine.

Authors:  D J Wedel; P A Iaizzo; J H Milde
Journal:  Anesthesiology       Date:  1991-03       Impact factor: 7.892

10.  Effects of isoflurane and nitrous oxide in subanesthetic concentrations on memory and responsiveness in volunteers.

Authors:  R Dwyer; H L Bennett; E I Eger; D Heilbron
Journal:  Anesthesiology       Date:  1992-11       Impact factor: 7.892

View more
  2 in total

1.  Anesthesia and global warming: the real hazards of theoretic science.

Authors:  George Mychaskiw Ii
Journal:  Med Gas Res       Date:  2012-03-25

2.  Remifentanil infusion during desflurane anesthesia reduces tissue blood flow while maintaining blood pressure and tissue oxygen tension in the masseter muscle and mandibular bone marrow.

Authors:  Ayaka Kobayashi; Masataka Kasahara; Kyotaro Koshika; Yui Akiike; Nobuyuki Matsuura; Tatsuya Ichinohe
Journal:  J Vet Med Sci       Date:  2020-11-16       Impact factor: 1.267

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.